| NDC Code | 70461-655-03 |
|---|
| Package Description | 10 SYRINGE, GLASS in 1 CARTON (70461-655-03) / .5 mL in 1 SYRINGE, GLASS (70461-655-04) |
|---|
| Product NDC | 70461-655 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Flucelvax |
|---|
| Non-Proprietary Name | Influenza A Virus A/georgia/12/2022 Cvr-167 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza A Virus A/victoria/800/2024 Cvr-289 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/singapore/wuh4618/2021 Antigen (mdck Cell Derived, Propiolactone Inactivated) |
|---|
| Dosage Form | INJECTION, SUSPENSION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20250701 |
|---|
| End Marketing Date | 20260731 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125408 |
|---|
| Manufacturer | Seqirus Inc. |
|---|
| Substance Name | INFLUENZA A VIRUS A/GEORGIA/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/800/2024 CVR-289 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/SINGAPORE/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) |
|---|
| Strength | 15; 15; 15 |
|---|
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL |
|---|